PolyActiva Secures $40M Series C to Advance Revolutionary Glaucoma Implant Technology
Melbourne-based PolyActiva raised $40 million in Series C funding, including $27 million from Australia's National Reconstruction Fund, to advance its biodegradable glaucoma treatment implant.